Respecting the distribution of MCs in the interstitial and perivascular sites, the COVID-19 group presented a higher number of IgE+ MCs than the CONTROL group (p < 0.0001); however, there was no statistical significance when compared with the H1N1 group. Here, IGHE is linked to COVID-19.